Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Forma Therapeutics Holdings Inc (FMTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2021	12-2020	12-2019	12-2018	12-2006
Cash Flows From Operating Activities
Net Income	-172,964	-70,414	-34,793	5,292	N/A
Depreciation Amortization	2,812	1,835	1,573	3,527	N/A
Accounts receivable	N/A	227	82,356	-56,272	N/A
Accounts payable and accrued liabilities	-173	933	-2,778	2,289	N/A
Other Working Capital	-3,155	-10,736	-2,806	-144,429	N/A
Other Operating Activity	23,693	-17,263	-78,042	56,763	0
Operating Cash Flow	$-149,787	$-95,418	$-34,490	$-132,830	$N/A

Cash Flows From Investing Activities
Change In Deposits	-51,196	-363,458	69,946	102,485	N/A
PPE Investments	-4,179	-203	-529	-3,391	N/A
Net Acquisitions	N/A	17,840	N/A	N/A	N/A
Investing Cash Flow	$-55,375	$-345,821	$69,417	$99,094	$N/A

Cash Flows From Financing Activities
Common Stock Issued	513	390	12	N/A	N/A
Other Financing Activity	-972	552,212	54,793	0	0
Financing Cash Flow	$-459	$552,602	$54,805	$N/A	$N/A

Beginning Cash Position	285,159	173,796	84,064	117,800	N/A
End Cash Position	79,538	285,159	173,796	84,064	N/A
Net Cash Flow	$-205,621	$111,363	$89,732	$-33,736	$N/A

Free Cash Flow
Operating Cash Flow	-149,787	-95,418	-34,490	-132,830	N/A
Capital Expenditure	-4,179	-249	-529	-3,391	N/A
Free Cash Flow	-153,966	-95,667	-35,019	-136,221	0